Skip to main content

Want a detailed portfolio tracker?

OverviewPerformanceMetricsFinancialsIndustrySplitsCorrelations
Market CapEPSP/EP/SP/BSharesProfit MarginOperating MarginDebt to EquityRevenueEarningsEBITDAFree Cash FlowTotal DebtTotal AssetsROAROE

Oncternal Therapeutics (ONCT) Operating Margin (2019 - 2024)

Oncternal Therapeutics (ONCT) operating margin from Jun 30, 2019 to Sep 30, 2024. The current Oncternal Therapeutics (ONCT) operating margin is -1771.43%. You can export chart.

Annual Operating Margin

Quarterly Operating Margin

Annual Operating Margin change of Oncternal Therapeutics (ONCT)

YearOperating MarginChange
2023-5279.75%
+75.01%
2022-3016.78%
+315.44%
2021-726.16%
+39.93%
2020-518.93%
-62.07%
2019-1368.18%
N/A

Comparison Oncternal Therapeutics (ONCT) operating margin with competitors

Oncternal Therapeutics (ONCT) operating margin is -1771.43%.

TickerNameOperating MarginUpside
VIRVir Biotechnology Inc459241.00%-26024.90%
APLMApollomics Inc - Class A431.90%-124.38%
ABUSArbutus Biopharma Corp94.30%-105.32%
SAVACassava Sciences Inc.93.36%-105.27%
RPRXRoyalty Pharma plc - Class A89.29%-105.04%
GLPGGalapagos NV84.24%-104.76%
NEUPNeuphoria Therapeutics Inc79.85%-104.51%
BDTXBlack Diamond Therapeutics Inc77.90%-104.40%
CTNMContineum Therapeutics Inc - Class A77.87%-104.40%
CVACCureVac N.V.74.59%-104.21%
IPSCCentury Therapeutics Inc67.95%-103.84%
FULCFulcrum Therapeutics Inc65.62%-103.70%
AVIRAtea Pharmaceuticals Inc63.06%-103.56%
PLXProtalix BioTherapeutics Inc62.65%-103.54%
PRTAProthena Corporation plc58.80%-103.32%
AUPHAurinia Pharmaceuticals Inc53.31%-103.01%
ADMAAdma Biologics Inc50.90%-102.87%
RPTXRepare Therapeutics Inc50.85%-102.87%
CRMDCorMedix Inc49.96%-102.82%
HCWBHCW Biologics Inc49.45%-102.79%
CPRXCatalyst Pharmaceuticals Inc49.02%-102.77%
SRPTSarepta Therapeutics Inc49.00%-102.77%
HALOHalozyme Therapeutics Inc48.98%-102.77%
KRYSKrystal Biotech Inc46.14%-102.60%
AGENAgenus Inc44.62%-102.52%
CGENCompugen Ltd43.05%-102.43%
SVASinovac Biotech Ltd42.30%-102.39%
EXELExelixis Inc41.15%-102.32%
QTTBQ32 Bio Inc39.80%-102.25%
INVAInnoviva Inc38.94%-102.20%
VRTXVertex Pharmaceuticals Inc38.10%-102.15%
NXTCNextcure Inc36.70%-102.07%
LGNDLigand Pharmaceuticals Inc - Class B33.58%-101.90%
SLNOSoleno Therapeutics Inc33.06%-101.87%
JAZZJazz Pharmaceuticals plc31.49%-101.78%
ARGXArgen X SE30.35%-101.71%
CAICaris Life Sciences Inc - Class A30.19%-101.70%
TNGXTango Therapeutics Inc26.15%-101.48%
GMABGenmab25.11%-101.42%
ZVRAZevra Therapeutics Inc24.40%-101.38%
TECHBio-Techne Corp24.24%-101.37%
INCYIncyte Corp23.66%-101.34%
RIGLRigel Pharmaceuticals20.21%-101.14%
ICCCImmucell Corp19.01%-101.07%
REGNRegeneron Pharmaceuticals Inc17.83%-101.01%
NERVMinerva Neurosciences Inc17.73%-101.00%
HRMYHarmony Biosciences Holdings Inc17.31%-100.98%
TGTXTG Therapeutics Inc16.98%-100.96%
BMRNBiomarin Pharmaceutical Inc16.92%-100.96%
PTCTPTC Therapeutics Inc16.50%-100.93%
PHARPharming Group N.V.16.26%-100.92%
ENVBEnveric Biosciences Inc13.38%-100.76%
VXRTVaxart Inc13.19%-100.74%
VRNAVerona Pharma Plc12.90%-100.73%
ALNYAlnylam Pharmaceuticals Inc12.01%-100.68%
ASNDAscendis Pharma A/S10.06%-100.57%
APLSApellis Pharmaceuticals Inc9.86%-100.56%
FOLDAmicus Therapeutics Inc8.61%-100.49%
CGEMCullinan Oncology Inc7.24%-100.41%
IMCRImmunocore Holdings plc6.82%-100.38%
NAGENiagen Bioscience Inc5.01%-100.28%
NUVBNuvation Bio Inc - Class A4.66%-100.26%
BMEABiomea Fusion Inc2.46%-100.14%
TLXTelix Pharmaceuticals Ltd1.58%-100.09%
HOTHHoth Therapeutics Inc0.17%-100.01%
BBLGBone Biologics Corp0.04%-100.00%